Data updated: Mar 10, 2026
WARFARIN SODIUM
WARFARIN SODIUM
Approved 1997-03-26
9
Indications
--
Phase 3 Trials
28
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1997-03-26
- Routes
- ORAL
- Dosage Forms
- TABLET
Companies
WATSON LABS USL PHARMA PLIVA ZYDUS PHARMS USA Teva Aurobindo Pharma CHARTWELL RX INVAGEN PHARMS TARO AMNEAL PHARMS AIPING PHARM INC
Active Ingredient: WARFARIN SODIUM
Website: ↗
WARFARIN SODIUM Approval History
Loading approval history...
What WARFARIN SODIUM Treats
9 FDA approvalsOriginally approved for its first indication in 1997 . Covers 9 distinct patient populations.
- Other (9)
Other
(9 approvals)- • Approved indication (Mar 1997)
- • Approved indication (Sep 1997)
- • Approved indication (Jul 1999)Label Letter
- • Approved indication (Sep 2004)
- • Approved indication (May 2006)
- • Approved indication (Jul 2006)
- • Approved indication (May 2011)
- • Approved indication (Mar 2013)
- • Approved indication (Jun 2013)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
WARFARIN SODIUM FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.